Allovir Inc (ALVR)

Jan 28, 2025

Allovir director Vikas Sinha sells $1,225 in stock - MSN

Jan 28, 2025

Jan 28, 2025

Allovir's chief accounting officer sells $342 in common stock - MSN

Jan 28, 2025

Jan 27, 2025

Allovir's general counsel sells $494 in stock - MSN

Jan 27, 2025

Jan 27, 2025

Allovir's general counsel sells $494 in stock By Investing.com - Investing.com South Africa

Jan 27, 2025

Jan 27, 2025

Allovir's chief accounting officer sells $342 in common stock By Investing.com - Investing.com South Africa

Jan 27, 2025

Jan 27, 2025

Allovir director Vikas Sinha sells $1,225 in stock By Investing.com - Investing.com Australia

Jan 27, 2025

Jan 27, 2025

Levi & Korsinsky Notifies Shareholders of AlloVir, Inc.(ALVR) of a Class Action Lawsuit and an Upcoming Deadline - GuruFocus.com

Jan 27, 2025

Jan 22, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerCYTH, ALVR, WMPN, OMC - Morningstar

Jan 22, 2025

Jan 21, 2025

ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Inve - GuruFocus.com

Jan 21, 2025

Jan 18, 2025

AlloVir (NASDAQ:ALVR) Trading 8.2% HigherHere's What Happened - MarketBeat

Jan 18, 2025

Jan 17, 2025

The Law Offices of Vincent Wong Remind AlloVir Investors of a Lead Plaintiff Deadline of March 19, 2024 - Marketscreener.com

Jan 17, 2025

Jan 17, 2025

Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class ActionALVR - Marketscreener.com

Jan 17, 2025

Jan 17, 2025

AlloVir (NASDAQ:ALVR) Hits New 1-Year LowWhat's Next? - MarketBeat

Jan 17, 2025

Jan 17, 2025

SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options - Marketscreener.com

Jan 17, 2025

Jan 17, 2025

ALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc.ALVR - Marketscreener.com

Jan 17, 2025

Jan 17, 2025

Shareholder Alert: Ademi LLP Investigates Whether AlloVir, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Marketscreener.com

Jan 17, 2025

Jan 17, 2025

AlloVir, Inc. Enter into Termination of Sublease Agreement with AMAG Pharmaceuticals, Inc - Marketscreener.com

Jan 17, 2025

Jan 17, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allovir - Marketscreener.com

Jan 17, 2025

Jan 17, 2025

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. LawsuitALVR - Marketscreener.com

Jan 17, 2025

Jan 16, 2025

Jane Street Group LLC Sells 89,680 Shares of AlloVir, Inc. (NASDAQ:ALVR) - Defense World

Jan 16, 2025

Jan 16, 2025

AlloVir executes reverse stock split By Investing.com - Investing.com Australia

Jan 16, 2025

Jan 15, 2025

AlloVir executes reverse stock split - Investing.com

Jan 15, 2025

Jan 15, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Jan 15, 2025

Jan 14, 2025

Allovir stock plunges to 52-week low, touches $0.4 By Investing.com - Investing.com Australia

Jan 14, 2025

Jan 13, 2025

Allovir’s Vikas Sinha sells shares worth $430 By Investing.com - Investing.com Nigeria

Jan 13, 2025

Jan 13, 2025

Allovir's Vikas Sinha sells shares worth $430 By Investing.com - Investing.com Australia

Jan 13, 2025

Jan 13, 2025

Allovir’s general counsel Edward Miller sells $180 in stock By Investing.com - Investing.com Nigeria

Jan 13, 2025

Jan 13, 2025

Allovir’s chief accounting officer sells $146 in common stock By Investing.com - Investing.com Nigeria

Jan 13, 2025

Jan 13, 2025

Allovir's chief accounting officer sells $146 in common stock By Investing.com - Investing.com Australia

Jan 13, 2025

Jan 13, 2025

Allovir's general counsel Edward Miller sells $180 in stock By Investing.com - Investing.com Australia

Jan 13, 2025

Jan 13, 2025

Allovir's chief accounting officer sells $146 in common stock - Investing.com India

Jan 13, 2025

Jan 13, 2025

Allovir's general counsel Edward Miller sells $180 in stock - Investing.com India

Jan 13, 2025

Jan 13, 2025

Allovir stock plunges to 52-week low, touches $0.4 - Investing.com India

Jan 13, 2025

Jan 13, 2025

Geode Capital Management LLC Lowers Stock Position in AlloVir, Inc. (NASDAQ:ALVR) - Defense World

Jan 13, 2025

Jan 12, 2025

Reviewing AlloVir (NASDAQ:ALVR) and Turnstone Biologics (NASDAQ:TSBX) - Defense World

Jan 12, 2025

Jan 12, 2025

AlloVir, Inc. Reports Positive Voting Outcome for Proposed Reverse Stock Split - Defense World

Jan 12, 2025

Jan 11, 2025

AlloVir announces reverse stock split effective January 16 By Investing.com - Investing.com Australia

Jan 11, 2025

Jan 11, 2025

AlloVir announces reverse stock split effective January 16 - Investing.com India

Jan 11, 2025

Jan 10, 2025

AlloVir shareholders approve reverse stock split - Investing.com

Jan 10, 2025